Jeffrey Del - Nov 21, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role: Chief Commercial Officer
Signature: /s/ Jeffrey Del Carmen
Stock symbol: CPRX
Transactions as of: Nov 21, 2024
Transactions value $: $0
Form type: 4
Date filed: 11/25/2024, 05:01 PM
Previous filing: Aug 13, 2024
Next filing: Dec 11, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CPRX	Options to purchase common stock	Award	$0	-138K	-12.75%	$0.00	942K	Nov 21, 2024	Common Stock	138K	$21.12	Direct	F1
transaction	CPRX	Restricted Stock Units	Award	$0	-16.8K	-1.72%	$0.00	958K	Nov 21, 2024	Common Stock	16.8K		Direct	F1, F2, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Derivative securities vest in equal tranches, 1/3rd on November 21, 2025, 1/3rd on November 21, 2026 and 1/3rd on November 21, 2027.
F2	Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F3	Shares of common stock will be delivered to the Reporting Person upon vesting.